Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 455

1.

Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation.

Arunkumar N, Liu C, Hang H, Song W.

Cell Mol Immunol. 2013 Jul;10(4):360-72. doi: 10.1038/cmi.2013.14. Epub 2013 Jun 3.

2.

CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation.

Lenert P, Stunz L, YI AK, Krieg AM, Ashman RF.

Antisense Nucleic Acid Drug Dev. 2001 Aug;11(4):247-56.

PMID:
11572601
3.

Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.

Liang X, Moseman EA, Farrar MA, Bachanova V, Weisdorf DJ, Blazar BR, Chen W.

Blood. 2010 Jun 17;115(24):5041-52. doi: 10.1182/blood-2009-03-213363. Epub 2010 Mar 25.

4.

A threshold level of TLR9 mRNA predicts cellular responsiveness to CpG-ODN in haematological and non-haematological tumour cell lines.

Assaf A, Esteves H, Curnow SJ, Browning MJ.

Cell Immunol. 2009;259(1):90-9. doi: 10.1016/j.cellimm.2009.06.003. Epub 2009 Jun 6.

PMID:
19573862
5.

Toll-like receptor 9 ligand blocks osteoclast differentiation through induction of phosphatase.

Amcheslavsky A, Bar-Shavit Z.

J Bone Miner Res. 2007 Aug;22(8):1301-10.

6.

Expression of Toll-like receptor9 in diffuse large B-cell lymphoma: further exploring CpG oligodeoxynucleotide in NFκB pathway.

Huang WT, Weng SW, Huang CC, Lin HC, Tsai PC, Chuang JH.

APMIS. 2012 Nov;120(11):872-81. doi: 10.1111/j.1600-0463.2012.02915.x. Epub 2012 May 28.

PMID:
23009111
7.

Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells.

He W, Zhang Y, Zhang J, Yu Q, Wang P, Wang Z, Smith AJ.

J Endod. 2012 Jun;38(6):780-5. doi: 10.1016/j.joen.2012.02.026. Epub 2012 Apr 4.

PMID:
22595112
8.

Phosphorothioate-modified CpG oligodeoxynucleotide (CpG ODN) induces apoptosis of human hepatocellular carcinoma cells independent of TLR9.

Zhang Y, Lin A, Zhang C, Tian Z, Zhang J.

Cancer Immunol Immunother. 2014 Apr;63(4):357-67. doi: 10.1007/s00262-014-1518-y. Epub 2014 Jan 23.

PMID:
24452201
9.

Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.

Vollmer J, Weeratna RD, Jurk M, Samulowitz U, McCluskie MJ, Payette P, Davis HL, Schetter C, Krieg AM.

Immunology. 2004 Oct;113(2):212-23.

10.

Interleukin (IL)-12 mediates the anti-osteoclastogenic activity of CpG-oligodeoxynucleotides.

Amcheslavsky A, Bar-Shavit Z.

J Cell Physiol. 2006 Apr;207(1):244-50.

PMID:
16402377
11.

CpG oligodeoxynucleotides rescue BKS-2 immature B cell lymphoma from anti-IgM-mediated growth inhibition by up-regulation of egr-1.

Han SS, Chung ST, Robertson DA, Chelvarajan RL, Bondada S.

Int Immunol. 1999 Jun;11(6):871-9.

PMID:
10360960
12.

Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.

Abu-Rish EY, Amrani Y, Browning MJ.

Rheumatology (Oxford). 2013 Jul;52(7):1190-201. doi: 10.1093/rheumatology/ket006. Epub 2013 Feb 21.

PMID:
23436580
13.

Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.

Vollmer J, Weeratna RD, Jurk M, Davis HL, Schetter C, Wüllner M, Wader T, Liu M, Kritzler A, Krieg AM.

J Leukoc Biol. 2004 Sep;76(3):585-93. Epub 2004 Jun 24.

PMID:
15218053
15.

Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.

Jahrsdörfer B, Wooldridge JE, Blackwell SE, Taylor CM, Griffith TS, Link BK, Weiner GJ.

J Leukoc Biol. 2005 Mar;77(3):378-87. Epub 2004 Dec 6.

PMID:
15582984
16.

CpG oligodeoxynucleotides induce IL-8 expression in CD34+ cells via mitogen-activated protein kinase-dependent and NF-kappaB-independent pathways.

Kim JM, Kim NI, Oh YK, Kim YJ, Youn J, Ahn MJ.

Int Immunol. 2005 Dec;17(12):1525-31. Epub 2005 Nov 1.

PMID:
16263754
17.

Species-Specific Minimal Sequence Motif for Oligodeoxyribonucleotides Activating Mouse TLR9.

Pohar J, Lainšček D, Fukui R, Yamamoto C, Miyake K, Jerala R, Benčina M.

J Immunol. 2015 Nov 1;195(9):4396-405. doi: 10.4049/jimmunol.1500600. Epub 2015 Sep 28.

18.

Toll-like receptor 9 regulates tumor necrosis factor-alpha expression by different mechanisms. Implications for osteoclastogenesis.

Amcheslavsky A, Zou W, Bar-Shavit Z.

J Biol Chem. 2004 Dec 24;279(52):54039-45. Epub 2004 Oct 14.

19.

Chicken TLR21 acts as a functional homologue to mammalian TLR9 in the recognition of CpG oligodeoxynucleotides.

Brownlie R, Zhu J, Allan B, Mutwiri GK, Babiuk LA, Potter A, Griebel P.

Mol Immunol. 2009 Sep;46(15):3163-70. doi: 10.1016/j.molimm.2009.06.002. Epub 2009 Jul 1.

PMID:
19573927
20.

CpG oligonucleotides induce an immune response of odontoblasts through the TLR9, MyD88 and NF-kappaB pathways.

He W, Yu Q, Zhou Z, Wang P.

Biochem Biophys Res Commun. 2010 Aug 20;399(2):274-8. doi: 10.1016/j.bbrc.2010.07.068. Epub 2010 Jul 21.

PMID:
20655295

Supplemental Content

Support Center